Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Global Antibiotics Market 2021-2025

Published by TechNavio (Infiniti Research Ltd.) Product code 1003715
Published Content info 120 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Antibiotics Market 2021-2025
Published: April 27, 2021 Content info: 120 Pages
Description

Technavio has been monitoring the antibiotics market and it is poised to grow by $ 13.72 bn during 2021-2025, progressing at a CAGR of over 5% during the forecast period. Our report on antibiotics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of infectious diseases and growing awareness of various diseases and their treatment. In addition, the rising prevalence of infectious diseases is anticipated to boost the growth of the market as well.

The antibiotics market analysis includes product segment, application segment, and geographic landscape.

Technavio's antibiotics market is segmented as below:

By Product

  • Broad-spectrum antibiotics
  • Narrow-spectrum antibiotics

By Application

  • Antibiotics for human use
  • Antibiotics for veterinary use

By Geographic

  • Asia
  • North America
  • Europe
  • ROW

This study identifies the special regulatory designationsas one of the prime reasons driving the antibiotics market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on antibiotics market covers the following areas:

  • Antibiotics market sizing
  • Antibiotics market forecast
  • Antibiotics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antibiotics market vendors that include Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bayer AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Mayne Pharma Group Ltd., Merck KGaA, Pfizer Inc., and Sanofi SA. Also, the antibiotics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents
Product Code: IRTNTR41323

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Broad-spectrum antibiotics - Market size and forecast 2020-2025
  • Narrow-spectrum antibiotics - Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • Asia - Market size and forecast 2020-2025
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • AbbVie Inc.
  • AstraZeneca Plc
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Mayne Pharma Group Ltd.
  • Merck KGaA
  • Pfizer Inc.
  • Sanofi SA

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Product - Market share 2020-2025 (%)
  • 22: Comparison by Product
  • 23: Broad-spectrum antibiotics - Market size and forecast 2020-2025 ($ million)
  • 24: Broad-spectrum antibiotics - Year-over-year growth 2020-2025 (%)
  • 25: Narrow-spectrum antibiotics - Market size and forecast 2020-2025 ($ million)
  • 26: Narrow-spectrum antibiotics - Year-over-year growth 2020-2025 (%)
  • 27: Market opportunity by Product
  • 28: Customer landscape
  • 29: Market share by geography 2020-2025 (%)
  • 30: Geographic comparison
  • 31: Asia - Market size and forecast 2020-2025 ($ million)
  • 32: Asia - Year-over-year growth 2020-2025 (%)
  • 33: North America - Market size and forecast 2020-2025 ($ million)
  • 34: North America - Year-over-year growth 2020-2025 (%)
  • 35: Europe - Market size and forecast 2020-2025 ($ million)
  • 36: Europe - Year-over-year growth 2020-2025 (%)
  • 37: ROW - Market size and forecast 2020-2025 ($ million)
  • 38: ROW - Year-over-year growth 2020-2025 (%)
  • 39: Key leading countries
  • 40: Market opportunity by geography ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Abbott Laboratories - Overview
  • 48: Abbott Laboratories - Business segments
  • 49: Abbott Laboratories - Key offerings
  • 50: Abbott Laboratories - Key customers
  • 51: Abbott Laboratories - Segment focus
  • 52: AbbVie Inc. - Overview
  • 53: AbbVie Inc. - Product and service
  • 54: AbbVie Inc. - Key offerings
  • 55: AbbVie Inc. - Key customers
  • 56: AbbVie Inc. - Segment focus
  • 57: AstraZeneca Plc - Overview
  • 58: AstraZeneca Plc - Product and service
  • 59: AstraZeneca Plc - Key offerings
  • 60: AstraZeneca Plc - Key customers
  • 61: AstraZeneca Plc - Segment focus
  • 62: Bayer AG - Overview
  • 63: Bayer AG - Business segments
  • 64: Bayer AG - Key offerings
  • 65: Bayer AG - Key customers
  • 66: Bayer AG - Segment focus
  • 67: F. Hoffmann-La Roche Ltd. - Overview
  • 68: F. Hoffmann-La Roche Ltd. - Business segments
  • 69: F. Hoffmann-La Roche Ltd. - Key offerings
  • 70: F. Hoffmann-La Roche Ltd. - Key customers
  • 71: F. Hoffmann-La Roche Ltd. - Segment focus
  • 72: Johnson & Johnson - Overview
  • 73: Johnson & Johnson - Business segments
  • 74: Johnson & Johnson - Key offerings
  • 75: Johnson & Johnson - Key customers
  • 76: Johnson & Johnson - Segment focus
  • 77: Mayne Pharma Group Ltd. - Overview
  • 78: Mayne Pharma Group Ltd. - Business segments
  • 79: Mayne Pharma Group Ltd. - Key offerings
  • 80: Mayne Pharma Group Ltd. - Key customers
  • 81: Mayne Pharma Group Ltd. - Segment focus
  • 82: Merck KGaA - Overview
  • 83: Merck KGaA - Business segments
  • 84: Merck KGaA - Key offerings
  • 85: Merck KGaA - Key customers
  • 86: Merck KGaA - Segment focus
  • 87: Pfizer Inc. - Overview
  • 88: Pfizer Inc. - Business segments
  • 89: Pfizer Inc. - Key offerings
  • 90: Pfizer Inc. - Key customers
  • 91: Pfizer Inc. - Segment focus
  • 92: Sanofi SA - Overview
  • 93: Sanofi SA - Business segments
  • 94: Sanofi SA - Key offerings
  • 95: Sanofi SA - Key customers
  • 96: Sanofi SA - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations
Back to Top